MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1038/s41434-021-00283-5

Медицинская библиотека · Gene therapy · 2021

Thrombopoietin-based CAR-T cells demonstrate in vitro and in vivo cytotoxicity to MPL positive acute myelogenous leukemia and hematopoietic stem cells.

Zoine Jaquelyn T, Prince Chengyu, Story Jamie Y, Branella Gianna M, Lytle Allison M, Fedanov Andrew, Alexander Jordan S, Porter Christopher C, Doering Christopher B, Spencer H Trent, Chandrakasan Shanmuganathan

СтатьяПоддержка NIH: внешняя программаПеревод пока не подготовлен

Аннотация

While targeting CD19+ hematologic malignancies with CAR T cell therapy using single chain variable fragments (scFv) has been highly successful, novel strategies for applying CAR T cell therapy with other tumor types are necessary. In the current study, CAR T cells were designed using a ligand binding domain instead of an scFv to target stem-like leukemia cells. Thrombopoietin (TPO), the natural ligand to the myeloproliferative leukemia protein (MPL) receptor, was used as the antigen binding domain to engage MPL expressed on hematopoietic stem cells (HSC) and erythropoietic and megakaryocytic acute myeloid leukemias (AML). TPO-CAR T cells were tested in vitro against AML cell lines with varied MPL expression to test specificity. TPO-CAR T cells were specifically activating and cytotoxic against MPL+ leukemia cell lines. Though the TPO-CAR T cells did not extend survival in vivo, it successfully cleared the MPL+ fraction of leukemia cells. As expected, we also show the TPO-CAR is cytotoxic against MPL expressing bone marrow compartment in AML xenograft models. The data collected demonstrate preclinical potential of TPO-CAR T cells for stem-like leukemia through assessment of targeted killing of MPL+ cells and may facilitate subsequent HSC transplant under reduced intensity conditioning regimens.

Для цитирования: Zoine Jaquelyn T, Prince Chengyu, Story Jamie Y, Branella Gianna M, Lytle Allison M, Fedanov Andrew, Alexander Jordan S, Porter Christopher C, Doering Christopher B, Spencer H Trent, Chandrakasan Shanmuganathan. Thrombopoietin-based CAR-T cells demonstrate in vitro and in vivo cytotoxicity to MPL positive acute myelogenous leukemia and hematopoietic stem cells.. Gene therapy. 2021. DOI: 10.1038/s41434-021-00283-5.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.